Oxycodone
(Redirected from OxyIR)
Oxycodone is a semisynthetic opioid analgesic, renowned for its efficacy in the management of moderate to moderately-severe pain conditions. Developed as an alternative to older opiate-based analgesics, oxycodone has become a pivotal player in pain management both as a standalone agent and in combination with other analgesics, notably acetaminophen.
Pharmacology and Mechanism of Action[edit | edit source]
Derived from thebaine, a natural alkaloid sourced from the resin of poppy seeds (Papaver somniferum), oxycodone operates by primarily targeting and activating the μ (mu) type opiate receptor in the central nervous system. This agonistic interaction results in a cascade of neurotransmitter activities culminating in pain modulation and suppression.
Oxycodone's effectiveness in alleviating pain makes it a primary choice for both acute and chronic pain management scenarios. Its history dates back to its synthesis in 1917, and after undergoing comprehensive evaluations, it received the US FDA approval in 1991.
Dosage, Formulations, and Administration[edit | edit source]
Oxycodone's oral bioavailability ensures its presence in multiple formulations tailored to varied clinical needs:
- Immediate-Release Tablets: Available in 5, 7.5, 10, and 20 mg doses.
- Extended-Release Tablets (OxyContin): Designed for 24-hour pain management, available in doses ranging from 10 to 80 mg.
- Capsules: Typically available in 5 mg.
- Suppositories: For patients unable to ingest orally, available in 10 and 20 mg.
- Oral Solutions: Varied concentrations available to cater to specific patient needs.
Combination Therapies and Brand Associations[edit | edit source]
For synergistic pain relief, oxycodone is often combined with other non-opioid analgesics. The most prevalent combination is with acetaminophen, but associations with aspirin and ibuprofen also exist. Widely recognized brand formulations include:
- Percocet (Oxycodone and Acetaminophen)
- Tylox (Oxycodone and Acetaminophen)
- Endocet (Oxycodone and Acetaminophen)
Adverse Effects and Clinical Cautions[edit | edit source]
While oxycodone's therapeutic relevance is unquestionable, its use can result in several side effects:
- Central Nervous System: Sedation, mental clouding, euphoria, agitation, headache, and dizziness.
- Respiratory: Notable respiratory depression, particularly in overdose scenarios.
- Gastrointestinal: Nausea, vomiting, constipation, diarrhea, and abdominal distension.
- Dermatological: Itching and occasional rashes.
Chronic exposure may lead to physical dependency, and abrupt cessation can induce withdrawal symptoms characterized by insomnia, restlessness, pain, and flu-like symptoms.
Regulatory and Abuse Concerns[edit | edit source]
Given its psychoactive properties, oxycodone falls under the Schedule II category of controlled substances. This DEA classification acknowledges its therapeutic potential but concurrently underscores its abuse liability.
Regrettably, oxycodone misuse has surged in recent decades. Certain formulations can be manipulated for intravenous administration, heightening abuse risks. This misuse trajectory sometimes culminates in illicit drug-seeking behaviors, with heroin becoming a cheaper, more accessible alternative in some regions.
To counteract this, pharmaceutical endeavors are underway to develop tamper-resistant oxycodone formulations to reduce its misuse potential.
Summary[edit | edit source]
Oxycodone stands as a testament to the duality of drug development - a potent pain modulator with undeniable therapeutic merit, yet a potential conduit for substance abuse and dependency. Its clinical use necessitates vigilant monitoring, patient education, and an unwavering commitment to ensuring patient safety and welfare.
Oxycodone Resources | |
---|---|
|
Full and partial opiod agonists:
- Alfentanil
- Butorphanol
- Codeine
- Diphenoxylate
- Fentanyl
- Heroin
- Hydrocodone
- Hydromorphone
- Levorphanol
- Loperamide
- Meperidine
- Methadone
- Morphine
- Opium
- Oxycodone
- Oxymorphone
- Pentazocine
- Remifentanil
- Sufentanil
- Tramadol
Opiate antagonists:
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD